LP
Lipocine Inc.
LPCN · NASDAQ
$2.16 +0.00% (+$0.00)
1M +4.85%
Market Cap $17.8M
P/E Ratio -
Div. Yield -
ROE 64.75%
Bulios Fair Price
$1.28
40.7% downside
Trenutna cena
$2.16
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica LPCN trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Weak
2/9Valuation
50 /100
Fair P/S 11.35x
P/B 0.82x
P/E N/A
Growth
78 /100
Growing Rev. growth 58.12%
Book val. growth 25.94%
EPS growth N/A
Profitability
20 /100
Weak Gross margin 98.10%
Net margin 755.13%
FCF margin 713.04%
Quality
1 /100
Poor ROIC 57.74%
ROE 64.75%
Asset turnover 0.07x
Debt
100 /100
Low Debt/Equity 0.00x
Current ratio 11.48x
Int. coverage N/A
Stability
18 /100
Unstable Beta 0.47x
Rev. volatility 581.50%
Profitable years 0
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o LPCN
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Mahesh V. Patel
Employees
14
Headquarters
Salt Lake City
Prihajajoči dogodki
05 NOV.
Earnings
Upcoming earnings report